• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Molecular mechanisms of ferroptosis and its role in the treatment of breast cancer

    2024-03-26 12:55:16JINGBoCHENHengyuWUHuangfu
    Journal of Hainan Medical College 2024年1期

    JING Bo, CHEN Heng-yu, WU Huang-fu?

    1. The Second Clinical College of Hainan Medical University, Haikou 571199, China

    2. Department of Breast & Thyroid Surgery, the Second Affiliated Hospital of Hainan Medical University, Haikou 570311, China

    Keywords:

    ABSTRACT Breast cancer is a critical threat to women around the globe.Current radio- and chemotherapy regimens can induce multiple drug-resistant effects, e.g., anti-apoptosis, anti-pyroptosis,and anti-necroptosis, causing a poor clinical response to therapy.Ferroptosis is a newly programmed cell death characterized by iron overload, the massive production of reactive oxygen species (ROS), and membrane lipid peroxidation.The occurrence of ferroptosis results from an imbalance between peroxidation mechanisms (execution systems) and antioxidation mechanisms (defense systems), including the iron metabolism pathway, amino acid metabolism pathway, and lipid metabolism pathway.Recently, the vital role of ferroptosis in various diseases, including cancer, hypertension, diabetes, and Alzheimer's, has been identified.Specifically, triggering ferroptosis in breast cancer cells can inhibit their proliferation and invasion, and improve the chemoradiotherapy sensitivity, which makes it a potential strategy for breast cancer therapy.This review summarizes the definition and features of ferroptosis,as well as its role in the treatment of breast cancer, aimed at providing a theoretical basis for future drug development.

    Breast cancer is the most common malignant tumor in women with a high fatality rate.According to the study of Harbeck et al., there are about 17 million newly diagnosed cases of breast cancer worldwide every year, and 5 million women die from this disease[1].Clinically, the main therapeutic methods for this disease include surgical resection, chemoradiotherapy, endocrine therapy,immunotherapy and targeted therapy.However, due to its high degree of malignancy and susceptibility to drug resistance, the prognosis of breast cancer patients is generally not ideal[2].In recent years, programmed cell death modes, such as apoptosis, necrosis,autophagy, pyrodeath and necrotic apoptosis, have been found to be closely related to the proliferation, migration and drug resistance of breast cancer cells[3].ferroptosis, a concept proposed by Dixon et al in 2012, is an iron-dependent, non-apoptotic programmed cell necrosis, mainly manifested by reactive oxygen species (ROS)accumulation and membrane lipid peroxidation damage, which ultimately leads to cell death[4].ferroptosis has been confirmed to enhance the sensitivity of breast cancer to radiotherapy and chemotherapy, inhibit the growth of breast cancer tissues, distant metastasis and recurrence of cancer tissues, etc., which makes the induction of ferroptosis a potential strategy for the treatment of breast cancer[5].This paper focuses on the mechanism of ferroptosis and its role in the treatment of breast cancer to provide theoretical support for further improvement of breast cancer treatment and targeted drug development.

    1.Characteristics of ferroptosis

    Ferroptosis is different from the known programmed cell death in morphological, biochemical and genetic aspects.Morphologically,the most prominent feature was the change of mitochondrial ultrastructure, which was manifested as obvious atrophy of mitochondria, increased membrane density and decreased or disappeared mitochondrial cristae, while the nucleus was normal in size and the nuclear chromatin was not condensed.In terms of biochemical characteristics, when ferroptosis occurs, intracellular iron and ROS levels are significantly increased, glutathione (GSH)is consumed, glutathione peroxidase 4 (GPX4) is inactivated and mitochondrial membrane potential is reduced[6].From the perspective of mechanism, several previously discovered programmed cell death are execution-centered.For example,apoptosis is mainly executed by the caspases family, pyroptosis is mainly executed by the gasdermins family, and necroptosis is mainly mediated by mixed-lineage kinase domain-like protein (MLKL)[7].As a unique mode of cell death, ferroptosis depends on the confrontation between the execution system and the defense buffer system[8].Its implementation mechanisms include iron accumulation,Fenton reaction, synthesis and peroxidation of Polyunsaturated fatty acid-phospholipid (PUFA-PLs), etc.The defense mechanism is mainly System Xc-/GSH/GPX4 system[9, 10].The mechanism by which ferroptosis occurs is shown in Figure 1.

    In addition, two non-classical antioxidant systems, FSP1-CoQH2 system and DHODH-CoQH2 system, are also generally recognized[11].

    Fig 1 Mechanisms of ferroptosis

    2.Ferroptosis regulates pathways for breast cancer therapy

    Breast cancer is the most common malignant tumor in Chinese women.At present, the treatment methods for breast cancer mainly include surgery, radiotherapy and chemotherapy, endocrine therapy and targeted therapy.Although some achievements have been made,drug resistance and radiotherapy insensitivity often occur in the later stage, making the prognosis of breast cancer patients not ideal.In recent years, studies have confirmed that a variety of drugs, active compounds and related nanomaterials can inhibit the growth of breast cancer tissues, enhance the sensitivity of cancer tissues to radiotherapy and chemotherapy, and inhibit the distant metastasis and recurrence of breast cancer by inducing ferroptosis, which makes the induction of ferroptosis a potential strategy for the treatment of breast cancer[11].The pathways by which ferroptosis regulates breast cancer treatment and drug resistance are shown in Table 1

    2.1 Accumulation of iron

    Circulating Fe3+can combine with transferrin (TF) to form TFFe3+complex, which is endocytosed to the cell through transferrin receptor 1 (TFR1) on the cell membrane surface and localized tothe endosome.In the endosome, Fe3+is reduced to Fe2+by the sixtransmembrane epithelial antigen of prostate 3 (STEAP3), which is released into the labile iron pool (LIP) of the cytosol with the help of divalent metal ion transporter 1 (DMT1).A part of intracellular Fe2+can combine with ferritin heavy chain (FTH1), be oxidized to Fe3+, and then bind to ferritin light chain (FTL) to form ferritin complex stored in the cell.When the intracellular Fe2+content is significantly increased, too much iron will combine with hydrogen peroxide (H2O2) to produce Fenton reaction.The generation of hydroxyl free radicals ( OH) with strong oxidation ability increases the intracellular ROS level, and further promotes the peroxidation of PUFA-PLs under the synergistic effect of ester oxygenase (LOX),leading to cell membrane rupture and ferroptosis[12].Tyrosine kinase inhibitor neratinib is a commonly used chemotherapeutic drug for the treatment of HER-2+ breast cancer patients.It can increase the expression of TFR1 in cancer cells, induce iron accumulation and ferroptosis, and inhibit brain metastasis of cancer tissues in vivo[13].Similarly, the synergistic anticancer effect of chemotherapy drugs siramesine and lapatinib can increase TF content, promote intracellular iron accumulation, and induce ferroptosis in TNBC cells to exert synergistic anticancer effect[14].

    Tab 1 Pathways by which ferroptosis regulates Breast cancer therapy

    Liu et al.found that transmembrane protein 189 (TMEM189) can inhibit autophagy of TNBC cancer cells, reduce TFR1 expression and intracellular lipic-ROS content, alleviate ferroptosis, and promote the growth of breast cancer in vivo[15], suggesting that TMEM189 inhibitors may have a good therapeutic effect on TNBC.Iron-saturation lactoferrin (Holo-Lf) combined with radiotherapy at a dose of 4 Gy can significantly enhance the ferroptosis induced by Erastin in TNBC, inhibit the proliferation and migration of cancer cells, and enhance the radiosensitivity[16].Shuganning injection(SGNI), a Chinese patent drug, can selectively up-regulate the expression of heme oxygenase-1 (HO-1) in TNBC cells, promote iron accumulation and ferroptosis in LIP, and inhibit the growth of breast cancer tissues in vitro and in vivo[17].Artemisinin can promote ferritinophagy, increase intracellular Fe2+content and ferroptosis in TNBC cells, enhance the sensitivity of cancer tissue to ferroptosis inducer RSL3, and inhibit the development of breast cancer in vivo[18].Holo-Lf, SGNI and artemisinin are promising candidates for the treatment of TNBC.

    In recent years, there have also been many reports on nanoparticles targeting breast cancer therapy by iron accumulation and ferroptosis mechanism.Xu et al.developed a Fe2+-based nanoorganic metal framework (MOF-Fe2+), which can efficiently deliver Fe2+to breast cancer cells, promote the Fenton reaction and the generation of large amount of ROS, induce ferroptosis, and effectively inhibit the growth of breast cancer tissues in vivo[19].Zhu et al.constructed a Fe3+ cross-linked nanoparticle loaded with trans-azo-conpratin(trans-Azo-CA4), which can specifically enter breast cancer cells.After being excited by infrared light, the loaded Fe3+is converted to Fe2+,triggering Fenton reaction and lipid peroxide accumulation,and inducing ferrodeath of cancer cells.After the application of this particle in mice, the volume of breast cancer was significantly reduced and the anti-tumor effect was good[20].Zhang et al.designed a cascade of heparanase-driven release nanoparticles loaded with doxorubicin (Dox), ferrocene (Fc), and TGF-β receptor inhibitor SB431542.After entering breast cancer cells, the nanoparticles can increase intracellular iron accumulation and ROS content through Dox and Fc, activate ferroptosis, and successfully prevent cancer tissue metastasis in mice [21].The efficacy of these nanoparticles in clinical application needs to be further confirmed.

    2.2 System Xc-/GSH/GPX4

    The System Xc-/GSH/GPX4 system is the most important antioxidant defense mechanism for ferroptosis[22].GPX4 is a GSHdependent key enzyme that cleans intracellular lipid-ROS, converts reduced GSH to oxidized GSH (GSSG), and degrades phospholipid hydroperoxides (PLOOH) to non-toxic fatty alcohols to maintain the homeostasis of membrane Lipid bilayer, which is a key step to inhibit ferroptosis[23].The vast majority of intracellular GSH is synthesized from glutamate, cysteine and glycine by catalytic enzymes.The glutamate-cystine reverse transport system (system Xc-) is the way for most cells to obtain cysteine.This system is composed of disulfide bonded heterodimers SLC7A11 and SLC3A2,which can transport intracellular glutamate to the outside of the cell and extracellular cystine to the inside of the cell at a ratio of 1:1[24].Inhibiting the activity of System Xc-/GSH/GPX4 axis is an effective way to prevent the growth of breast cancer and treat breast cancer.

    2.2.1 GPX4

    Clinical studies have found that dihydroisotanshinone Ⅰ, the active component of salvia miltiorrhiza, can inhibit the expression of GPX4 in breast cancer cells, promote ferroptosis, and inhibit the growth of tumor tissues in mice without showing significant side effects[25].DMOCPTL, a derivative of natural product parthenolide, can directly bind to GPX4 protein to promote GPX4 ubiquitination and induce ferroptosis in breast cancer cells.In vivo, DMOCPTL can effectively inhibit the growth of mouse mammary tumors and significantly prolong the life span of mice without obvious toxicity[26].Wen et al.extracted the active compound glycyrrhetinic acid from the traditional herb licorice, and found that it could reduce the activities of GSH and GPX4, aggravate lipid peroxidation, and induce ferroptosis in breast cancer cells[27].Metformin can up-regulate the level of miR-324-3p in TNBC cells, target inhibition, promote ferroptosis, and significantly reduce the growth of cancer tissues in vivo[28].In addition, Jaggupilli et al.found that V9302, a small molecule compound that inhibits glutamine uptake, induces lipid peroxidation and promotes ferroptosis in TNBC cells by significantly inhibiting GSH and GPX4 activities in SUM159 and MDA-MB-231 cells.In vitro and in vivo combined with paclitaxel can significantly inhibit the growth of breast cancer[29].Dihydroisotanshinone Ⅰ, DMOCPTL, glycyrrhetinic acid, metformin and V9302 may be effective potential drugs for the treatment of breast cancer.

    Yao et al.reported that simvastatin (SIM) can attenuate 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) activity to inhibit mevalonate (MVA) pathway and GPX4 expression, thereby inducing ferroptosis in TNBC cancer cells.They further loaded SIM into zwitzwitzonic polymer-coated magnetic nanoparticles (Fe3O4@PCBMA) and achieved good anti-breast cancer effect in vivo.At present, Fe3O4 has been proved to be clinically available by the US Food and Drug Administration (FDA), and Fe3O4@PCBMA-SIM nanosystems may have great potential for clinical application[30].

    2.2.2 GSH

    Li et al.found that tumor-associated macrophages (TAMs)can secrete transforming growth factor β1 (TGF-β1) and upregulate the expression of hepatic leukemia factor (HLF) in TNBC cells, which makes breast cancer tissue larger and less sensitive to chemotherapy drug cisplatin.Mechanistically, HLF transcriptionally activates γ-glutamyl transpeptidase (GGT1), which catalyzes the cleavage of extracellular GSH and increases GSH content in cancer cells, thereby inhibiting ferroptosis and enhancing the proliferation and invasion ability of TNBC cells and the resistance of cancer tissues to cisplatin[31].Zou et al.identified fibroblast growth factor receptor 4 (FGFR4) as an essential gene for the acquisition of drug resistance in HER2+ breast cancer, and inhibition of FGFR4 in mice in vivo reduced GSH synthesis and Fe2+efflux efficiency through the β-catenin/TCF4-SLC7A11/FPN1 axis.It leads to excessive ROS production, iron accumulation and ferroptosis in LIP, and enhances the sensitivity of drug-resistant HER2+ breast cancer to chemotherapeutic drugs[32].HLF and FGFR4 may be the targets of drug development for the prevention and treatment of breast cancer.New breast cancer prevention and treatment materials targeting GSH and ferroptosis have also been reported in recent years.A sonodynamic sensitizer containing platinum (ii) -indocyanine complex can enhance the sensitivity of cancer tissue to ultrasound radiation therapy by reducing GSH content in TNBC cell line 4T1,promoting ROS generation and ferroptosis[33].Zhou et al.used cinnamaldehyde as a material to make a dimer capable of consuming GSH.When combined with sorafenib, this dimer significantly enhanced ferroptosis of 4T1 cancer cells and successfully cured breast cancer in mice in vivo by promoting dendritic cell maturation and CD8+T cell priming[34].

    2.2.3 System Xc-

    Actin-binding protein 1 (fascin) can directly bind to System Xc-,degrade System Xc- through the ubiquitin-proteasome system,enhance the sensitivity of MCF7 cells to Erastin, and inhibit the growth of breast cancer in vivo[35].The chemotherapeutic drug sulfasalazine can promote ferroptosis of breast cancer cells by specifically inhibiting the function of SLC3A1, and the use of this function to treat breast cancer has been in phase II clinical trials[36].Metformin can inhibit the UFMylation modification of SLC7A11,down-regulate the expression of SLC7A11, promote the ferroptosis of TNBC cancer cells, reduce the volume of breast cancer in vivo,and the effect is better when combined with sulfasalazine[37].Isoglycyrrhizin can inhibit the NF-κB signaling pathway in MDAMB-231 and MCF-7 cells, reduce the expression of System Xc-,promote ferroptosis, and reduce the resistance of breast cancer tissue to doxorubicin[38].Trastuzumab can increase the expression of circular RNA BGN (circ-BGN) in breast cancer cells BT474 and SKBR3, enhance the deubiquitination and expression of SLC7A11,inhibit ferroptosis, and induce drug resistance in cancer tissues,which can be reversed by Erastin[39].

    2.3 ACSL4

    The synthesis and peroxidation of PUFA-PLs is a prerequisite and key step for ferroptosis.Compared with monounsaturated fatty acids(MUFA), there are easily oxidized diallyl groups in PUFA, especially PUFA-PLS (PUFA-PE) containing phosphatidylethanolamine (PE)are most likely to undergo peroxidation under the catalysis of iron,which leads to the accumulation of a large amount of lipid peroxides in the cell membrane, cell membrane rupture and ferrodeath[40].Acyl-coa synthetase long-chain family member 4 (ACSL4) and lyso phosphatidylphosphatidyltransferase 3 (LPCAT3) are key enzymes in the synthesis of PUFA-PE[41, 42].ACSL4 can combine free PUFAs with coenzyme A (CoA) through acylation to form PUFA-CoA,which then occurs esterification under the action of LPCAT3 and reacts with PE to form PUFA-PE[43].Sha et al.collected biopsy specimens from 199 breast cancer patients who received paclitaxelcisplatin chemotherapy, and found that both ACSL4 expression and ACSL4/GPX4 combination status were independent predictors of achieving a pathological complete response (PCR) by rank test and Cox proportional regression.Moreover, ACSL4 expression is positively correlated with the overall survival rate of patients[44].The increased expression of ACSL4 in TNBC cell line MDA-MB-157 can enhance the sensitivity of cancer tissues to the ferroptosis inducer RSL3, while after knocking out ACSL4, cancer cells will not be induced to ferroptosis by RSL3, and the volume of cancer tissues in vivo becomes larger[45].These clues suggest that ACSL4 is a target for drug development in the treatment of TNBC.

    2.4 ACSL3/SCD1

    In contrast to ACSL4, MUFas such as octadecenoic acid mediated by ACSL3 or stearoyl-coa desaturase 1 (SCD1) competitively inhibit PUFA-related ferroptosis by substituting PLs in the cell membrane to form MUFA-PL.Studies have shown that inactivation of ACSL3 or SCD1 enhances the sensitivity of breast cancer cells to ferroptosis[46, 47].Luis et al.reported that SCD1 and fatty acid binding protein 4 (FABP4) were significantly up-regulated in human breast cancer specimens and were associated with poor prognosis in different types of breast cancer.Mechanistically, SCD1 can catalyze fatty acid desaturation and cooperate with FABP4 in the breast cancer microenvironment to promote lipid droplet formation,reduce hypoxia-induced ferroptosis, and promote cancer regrowth and recurrence.Down-regulation of SCD1 and FABP4 expression in vivo can significantly inhibit lipid transport in the cancer microenvironment and induce ferroptosis.Reduce the recurrence and metastasis of breast cancer[48].Cannabinoid receptor 1 (CB1)inhibitor rimonabant can activate PI3K and MAPK signaling pathways, reduce SCD1 and fatty acyl dessaturated enzyme 2(FADS2) -mediated MUFA production, promote ferroptosis of TNBC cells and the sensitivity of cancer tissues to Erastin and RSL3,and limit the growth of breast cancer tissues in vivo[49].Rimonabant may be an effective drug for the treatment of breast cancer, and the specific mechanism needs to be further confirmed.

    2.5 Nrf2

    Nuclear factor erythroid 2-related factor 2 (Nrf2) is a very important transcription factor for oxidative stress response, which can induce the expression of HO-1 and inhibit the expression of ROS, and exert anti-inflammatory and anti-ferroptosis effects.In recent years, it has been found that Nrf2 plays an important role in the progression,treatment and drug resistance of breast cancer.Jiang et al.found that TYRO3 expression in breast cancer tissues was associated with poor prognosis in breast cancer patients treated with anti-PD-1 /PD-L1 therapy.Mechanistically, anti-PD-1 /PD-L1 can induce a significant increase in TYRO3 expression in breast cancer tissues,further increase intracellular Nrf2 level, reduce ROS generation,and create a microenvironment conducive to tumor growth by inhibiting ferroptosis, making them resistant to anti-PD-1 /PDL1[50].Wu et al.reported that the expression of glycogen synthase kinase-3β (GSK-3β) was decreased, while Nrf2 was significantly overexpressed in breast cancer tissues.Overexpression of GSK-3β in TNBC cells inhibited Nrf2 expression, increased ROS and MDA content, and enhanced erastin-triggered ferroptosis.In the breast cancer xenograft model in vivo, overexpression of GSK-3β enhanced the effect of erastin-induced inhibition of tumor growth[51].Levistilide A, an active compound extracted from Ligusticum chuanxiong, can damage the mitochondrial structure and function of breast cancer cells by activating the Nrf2/HO-1 signaling pathway,and enhance ROS-induced ferroptosis in TNBC cells.Levistilide A may be a potential lead compound for breast cancer treatment[52].BET inhibitor (BETi) is a commonly used chemotherapeutic drug in the treatment of breast cancer, and its resistance is mainly mediated by NR5A2 and NCOA3.Mechanistically, NR5A2 interacts with NCOA3 to increase Nrf2 expression and inhibit ferroptosis in cancer cells.Inhibition of NR5A2 or NCOA3 using small molecule inhibitors can significantly enhance the anti-cancer effect of BETi on breast cancer in vitro and in vivo[53].

    2.6 FSP1-CoQH2

    Ferroptosis inhibitor protein 1 (FSP1), which inhibits ferroptosis independently of GPX4, is a flavoprotein encoded by a gene thought to be a p53-responsive gene[54], which is anchored to the cell membrane after N-terminal acylation and oxidize NAD(P)H to NAD(P)+ using FAD as a cofactor.At the same time, the generated reduced coenzyme Q (CoQH2) can reduce toxic lipid peroxides to non-toxic lipid alcohols[54], thereby inhibiting the process of lipid peroxidation and playing the role of anti-ferroptosis.FSP1 is a glutathione independent iron repressor[55] and a novel anti-ferroptosis biomarker[56].Silk fibroin nanoparticles coated with rosuvastatin can effectively inhibit the oxidoreductase activity of FSP1 and slow down the malignant progression of triple negative breast cancer[57].

    2.7 DHODH-CoQH2

    Dihydroorotate dehydrogenase (DHODH), which is present in the mitochondrial inner membrane, participates in the synthesis of pyrimidine and can reduce CoQ to CoQH2 in the mitochondrial inner membrane.When DHODH is activated, the production of CoQH2 increases, thereby inhibiting the process of lipid peroxidation in mitochondria[58], thus exerting an anti-ferroptosis effect.The DHODH inhibitor Breqinar selectively inhibits tumor growth with low GPX4 expression by inducing ferroptosis, while combination therapy with Breqinar and sulfasalazine synergistically induces ferroptosis and inhibits tumor growth with low GPX4 expression[58].DHODH inhibitor siR/IONs@LDH can induce ferroptosis in breast tumors[59].

    3.Summary and Prospect

    At present, targeted ferroptosis has been recognized as an effective method for the treatment of breast cancer, but its clinical application still faces many challenges.Firstly, most of the studies only carried out in vitro experiments, and the in vivo experiments were relatively ignored, so it is difficult to measure the effect of ferroptosis inducers on the growth and invasion of breast cancer tissues at the overall level.Moreover, the optimal dose of ferroptosis inducers in the treatment of breast cancer is rarely studied.Secondly, ferroptosis occurs not only in breast cancer tissues, but also in normal tissues.Therefore, ferroptosis inducers can not only kill tumor cells, but also cause harm to normal cells.TNBC is a type of breast cancer with the most difficult to treat and the highest recurrence rate in clinical practice.It has not been reported whether TNBC can be reedited to make it more sensitive to ferroptosis.Similar to the role of caspases, MLKL, GSDMs in other programmed death, what is the most representative marker of ferroptosis? Like other types of programmed cell death, ferroptosis has been found to play a doubleedged sword role in cancer, which depends on the release of damprelated molecular patterns in the tumor microenvironment and the activation of immune response triggered by ferroptosis damage.Therefore, how to reduce the side effects of ferroptosis inducers in the treatment of breast cancer is also an important problem.To solve these problems, future research should focus on both basic experiments and clinical trials, not only to explore the regulatory mechanism of ferroptosis, but also to pay attention to the changes in the function of various organs.It is possible to envisage that new treatment schemes designed for ferroptosis will be an important direction for the prevention and treatment of breast cancer in the future.

    av网站免费在线观看视频| 亚洲国产欧美一区二区综合| 十八禁网站免费在线| 国产三级黄色录像| 人人妻人人澡人人爽人人夜夜| 久久久久久久午夜电影 | 999久久久精品免费观看国产| 美国免费a级毛片| 亚洲自偷自拍图片 自拍| 亚洲av片天天在线观看| 亚洲一区二区三区不卡视频| 亚洲va日本ⅴa欧美va伊人久久| 亚洲欧美一区二区三区久久| 色在线成人网| 日韩欧美一区视频在线观看| 亚洲全国av大片| 精品少妇一区二区三区视频日本电影| 欧美日韩黄片免| 欧美+亚洲+日韩+国产| 亚洲色图av天堂| 美女视频免费永久观看网站| 欧美 日韩 精品 国产| 日韩欧美国产一区二区入口| av天堂在线播放| 欧美日韩国产mv在线观看视频| 久热爱精品视频在线9| 操美女的视频在线观看| 亚洲av第一区精品v没综合| 成在线人永久免费视频| 亚洲成人国产一区在线观看| 国产一区二区三区综合在线观看| 精品国产美女av久久久久小说| 日韩欧美国产一区二区入口| av视频免费观看在线观看| 国产一区有黄有色的免费视频| 午夜两性在线视频| 欧美日韩精品网址| 久久国产精品影院| 亚洲专区国产一区二区| 色婷婷久久久亚洲欧美| 91大片在线观看| 亚洲一区二区三区不卡视频| 精品人妻熟女毛片av久久网站| 国产精品香港三级国产av潘金莲| 国产91精品成人一区二区三区| 成年人免费黄色播放视频| 午夜福利免费观看在线| 日本a在线网址| 麻豆av在线久日| 成人黄色视频免费在线看| 日本撒尿小便嘘嘘汇集6| 法律面前人人平等表现在哪些方面| aaaaa片日本免费| 午夜老司机福利片| 精品欧美一区二区三区在线| av一本久久久久| 脱女人内裤的视频| 日韩免费高清中文字幕av| 水蜜桃什么品种好| 丰满饥渴人妻一区二区三| 9色porny在线观看| 欧美 亚洲 国产 日韩一| 成人永久免费在线观看视频| 日日摸夜夜添夜夜添小说| 男人操女人黄网站| 精品久久久久久久毛片微露脸| 丰满饥渴人妻一区二区三| 国产精品免费大片| 视频区图区小说| 午夜福利免费观看在线| 热re99久久精品国产66热6| www日本在线高清视频| 脱女人内裤的视频| 午夜精品在线福利| 亚洲精品粉嫩美女一区| 国产蜜桃级精品一区二区三区 | 好看av亚洲va欧美ⅴa在| 国产国语露脸激情在线看| 久久99一区二区三区| 亚洲成av片中文字幕在线观看| 纯流量卡能插随身wifi吗| 999久久久精品免费观看国产| 每晚都被弄得嗷嗷叫到高潮| 久久精品国产a三级三级三级| 岛国毛片在线播放| 黄色片一级片一级黄色片| 国精品久久久久久国模美| 亚洲国产欧美日韩在线播放| 美女高潮到喷水免费观看| 午夜精品久久久久久毛片777| 淫妇啪啪啪对白视频| 不卡一级毛片| 久久久水蜜桃国产精品网| 国产av又大| 国产成人av激情在线播放| 黄网站色视频无遮挡免费观看| 国产深夜福利视频在线观看| 日韩免费av在线播放| 亚洲美女黄片视频| 亚洲国产精品sss在线观看 | 久久影院123| 男女高潮啪啪啪动态图| 免费观看精品视频网站| 国产免费男女视频| 在线播放国产精品三级| 久久久久国产一级毛片高清牌| 国产高清国产精品国产三级| 一区二区三区国产精品乱码| 亚洲国产精品合色在线| 精品国产亚洲在线| 91字幕亚洲| 黄色 视频免费看| 自线自在国产av| 午夜免费观看网址| 国产精品自产拍在线观看55亚洲 | 精品卡一卡二卡四卡免费| 一级毛片精品| 在线十欧美十亚洲十日本专区| 国产免费男女视频| 岛国在线观看网站| 亚洲 欧美一区二区三区| 99久久99久久久精品蜜桃| 老司机在亚洲福利影院| 中文字幕制服av| 一a级毛片在线观看| 精品人妻熟女毛片av久久网站| 国产成人精品久久二区二区91| 免费在线观看亚洲国产| 男女那种视频在线观看| 天堂av国产一区二区熟女人妻| 亚洲无线观看免费| 特级一级黄色大片| 日韩中文字幕欧美一区二区| 岛国在线观看网站| 亚洲电影在线观看av| 亚洲乱码一区二区免费版| 亚洲成人中文字幕在线播放| 哪里可以看免费的av片| 欧美一区二区国产精品久久精品| 国产伦人伦偷精品视频| 嫩草影院入口| 午夜a级毛片| 成人特级av手机在线观看| 精品免费久久久久久久清纯| 国产精品久久久久久人妻精品电影| 欧美xxxx黑人xx丫x性爽| 国产淫片久久久久久久久 | 日韩av在线大香蕉| 亚洲成人久久爱视频| 亚洲人成网站高清观看| 亚洲色图av天堂| 国产精品久久久人人做人人爽| 天天躁日日操中文字幕| 制服人妻中文乱码| ponron亚洲| 国产一区二区三区在线臀色熟女| 欧美极品一区二区三区四区| 中文亚洲av片在线观看爽| 亚洲精品美女久久久久99蜜臀| 成人性生交大片免费视频hd| 成人永久免费在线观看视频| 婷婷六月久久综合丁香| 在线观看免费午夜福利视频| 欧美乱色亚洲激情| 国产不卡一卡二| 日韩欧美精品免费久久 | 国产亚洲精品久久久久久毛片| 99热只有精品国产| 精品无人区乱码1区二区| 欧美高清成人免费视频www| 18禁黄网站禁片免费观看直播| 一个人观看的视频www高清免费观看| 午夜久久久久精精品| 亚洲成人久久性| av在线天堂中文字幕| 亚洲av不卡在线观看| 欧美区成人在线视频| 亚洲内射少妇av| e午夜精品久久久久久久| 国内精品一区二区在线观看| 国产成年人精品一区二区| 无人区码免费观看不卡| 激情在线观看视频在线高清| www.999成人在线观看| 亚洲人与动物交配视频| 亚洲欧美日韩东京热| 久久99热这里只有精品18| 精品一区二区三区视频在线 | 亚洲av一区综合| 亚洲国产精品久久男人天堂| 日本免费一区二区三区高清不卡| 51午夜福利影视在线观看| 久久伊人香网站| 12—13女人毛片做爰片一| 欧美性感艳星| 国产色爽女视频免费观看| 国产乱人视频| 99国产精品一区二区蜜桃av| 精品国内亚洲2022精品成人| 欧美bdsm另类| 精品熟女少妇八av免费久了| 国产精品一区二区三区四区免费观看 | 老熟妇仑乱视频hdxx| 叶爱在线成人免费视频播放| 蜜桃久久精品国产亚洲av| 成年女人看的毛片在线观看| 制服丝袜大香蕉在线| 国产高清videossex| 午夜福利高清视频| 色播亚洲综合网| 最新美女视频免费是黄的| 精品人妻偷拍中文字幕| 免费人成视频x8x8入口观看| 国产精品电影一区二区三区| 最新中文字幕久久久久| 国产精品美女特级片免费视频播放器| 婷婷精品国产亚洲av| 亚洲精品美女久久久久99蜜臀| 色视频www国产| 在线a可以看的网站| 19禁男女啪啪无遮挡网站| 亚洲欧美精品综合久久99| 久久精品91蜜桃| 最近视频中文字幕2019在线8| 精品久久久久久成人av| 三级国产精品欧美在线观看| 久久中文看片网| 国产成人福利小说| 免费在线观看日本一区| 天堂网av新在线| 欧美日韩精品网址| 大型黄色视频在线免费观看| 欧美日本视频| 岛国在线观看网站| 成人av一区二区三区在线看| 男人舔奶头视频| 啦啦啦免费观看视频1| 国产91精品成人一区二区三区| 19禁男女啪啪无遮挡网站| 精品免费久久久久久久清纯| 一本一本综合久久| 欧美中文日本在线观看视频| 熟女人妻精品中文字幕| 性欧美人与动物交配| 亚洲av电影不卡..在线观看| 99久久成人亚洲精品观看| 成人一区二区视频在线观看| 国产亚洲精品综合一区在线观看| 少妇的逼水好多| 精品福利观看| 12—13女人毛片做爰片一| 欧美av亚洲av综合av国产av| 97超视频在线观看视频| 乱人视频在线观看| 男插女下体视频免费在线播放| 啦啦啦观看免费观看视频高清| 亚洲精品在线美女| 波多野结衣高清作品| 可以在线观看的亚洲视频| 欧美日本视频| 一级a爱片免费观看的视频| 岛国在线免费视频观看| 欧美国产日韩亚洲一区| 中文亚洲av片在线观看爽| 长腿黑丝高跟| 免费在线观看成人毛片| 欧美+日韩+精品| 日韩成人在线观看一区二区三区| 国产野战对白在线观看| 免费大片18禁| 少妇的丰满在线观看| 免费人成在线观看视频色| 亚洲人成伊人成综合网2020| 99久久精品一区二区三区| 一区二区三区高清视频在线| 变态另类丝袜制服| 黄色日韩在线| 免费大片18禁| 老司机福利观看| 九九在线视频观看精品| 亚洲精品美女久久久久99蜜臀| 非洲黑人性xxxx精品又粗又长| 小蜜桃在线观看免费完整版高清| 人人妻,人人澡人人爽秒播| 十八禁网站免费在线| 成人无遮挡网站| 尤物成人国产欧美一区二区三区| 伊人久久精品亚洲午夜| 欧美av亚洲av综合av国产av| 精品免费久久久久久久清纯| 校园春色视频在线观看| 久久精品亚洲精品国产色婷小说| 老司机午夜十八禁免费视频| 国产成人av激情在线播放| 日韩中文字幕欧美一区二区| 国产私拍福利视频在线观看| 国产精品嫩草影院av在线观看 | 人人妻人人看人人澡| 日本与韩国留学比较| 狠狠狠狠99中文字幕| 高清在线国产一区| 国产一级毛片七仙女欲春2| 国产精品日韩av在线免费观看| 夜夜夜夜夜久久久久| 国产精品乱码一区二三区的特点| 99久久精品热视频| 1024手机看黄色片| 高潮久久久久久久久久久不卡| 国产真人三级小视频在线观看| 无人区码免费观看不卡| 日本免费一区二区三区高清不卡| 午夜精品久久久久久毛片777| 91九色精品人成在线观看| eeuss影院久久| 热99re8久久精品国产| 国产精品亚洲一级av第二区| 久久精品91无色码中文字幕| netflix在线观看网站| 婷婷精品国产亚洲av在线| 免费观看的影片在线观看| 国产亚洲精品av在线| 啦啦啦免费观看视频1| 少妇人妻精品综合一区二区 | 日韩人妻高清精品专区| 麻豆国产av国片精品| 国产精品98久久久久久宅男小说| 日本a在线网址| 色综合婷婷激情| 亚洲av成人av| 欧美国产日韩亚洲一区| 日韩欧美国产一区二区入口| 99久久无色码亚洲精品果冻| 美女被艹到高潮喷水动态| 久久精品国产清高在天天线| 国产高清videossex| 国产一区二区在线观看日韩 | 国产一区二区三区视频了| 一边摸一边抽搐一进一小说| 在线a可以看的网站| 91久久精品国产一区二区成人 | 19禁男女啪啪无遮挡网站| 日本一本二区三区精品| 草草在线视频免费看| 国产成人欧美在线观看| 色在线成人网| 美女高潮的动态| 日韩人妻高清精品专区| 国产麻豆成人av免费视频| 国产免费一级a男人的天堂| 男人的好看免费观看在线视频| 国产乱人伦免费视频| 91在线精品国自产拍蜜月 | 一边摸一边抽搐一进一小说| 欧美区成人在线视频| 亚洲精品影视一区二区三区av| 岛国在线观看网站| 免费人成视频x8x8入口观看| 国产乱人伦免费视频| 欧美zozozo另类| 老司机深夜福利视频在线观看| 淫秽高清视频在线观看| 在线国产一区二区在线| 国产一区二区激情短视频| 免费观看精品视频网站| 亚洲国产欧美人成| 一区二区三区国产精品乱码| 舔av片在线| 免费av观看视频| 国产一区二区激情短视频| 啦啦啦韩国在线观看视频| 亚洲18禁久久av| 黑人欧美特级aaaaaa片| 亚洲精品美女久久久久99蜜臀| 国产精品一区二区免费欧美| 亚洲精品美女久久久久99蜜臀| 国产成人a区在线观看| 国产精品,欧美在线| 级片在线观看| 免费av毛片视频| 色尼玛亚洲综合影院| 久久这里只有精品中国| 一本精品99久久精品77| 97超视频在线观看视频| 国产探花在线观看一区二区| 有码 亚洲区| 国产探花在线观看一区二区| 久久精品综合一区二区三区| 亚洲中文日韩欧美视频| or卡值多少钱| 国产伦一二天堂av在线观看| 最近最新中文字幕大全免费视频| 手机成人av网站| 亚洲国产精品成人综合色| 99久久九九国产精品国产免费| 两个人视频免费观看高清| 99国产精品一区二区三区| 天美传媒精品一区二区| 老熟妇乱子伦视频在线观看| 欧美成人一区二区免费高清观看| 又紧又爽又黄一区二区| 亚洲最大成人手机在线| 久久久久久九九精品二区国产| 久99久视频精品免费| 91字幕亚洲| 国产中年淑女户外野战色| 此物有八面人人有两片| 欧美黄色淫秽网站| 少妇丰满av| 久久伊人香网站| 欧美午夜高清在线| xxx96com| 国产亚洲欧美在线一区二区| 久久精品国产综合久久久| 极品教师在线免费播放| 国产精品乱码一区二三区的特点| 欧美黑人巨大hd| 又紧又爽又黄一区二区| 男人和女人高潮做爰伦理| 日韩欧美 国产精品| 在线观看日韩欧美| 日本五十路高清| 最新在线观看一区二区三区| 日韩 欧美 亚洲 中文字幕| 法律面前人人平等表现在哪些方面| 精品国产三级普通话版| 欧美极品一区二区三区四区| 日韩中文字幕欧美一区二区| 精品免费久久久久久久清纯| 免费人成在线观看视频色| 成人三级黄色视频| 一个人观看的视频www高清免费观看| 免费在线观看亚洲国产| av中文乱码字幕在线| 久久人妻av系列| 欧美日本亚洲视频在线播放| 久久午夜亚洲精品久久| 亚洲欧美日韩东京热| 麻豆国产97在线/欧美| 精品久久久久久成人av| 日韩免费av在线播放| 免费看十八禁软件| 亚洲一区二区三区不卡视频| 亚洲精品色激情综合| 精品久久久久久成人av| 午夜福利在线在线| 母亲3免费完整高清在线观看| 亚洲成av人片在线播放无| 亚洲熟妇中文字幕五十中出| 亚洲精品456在线播放app | 亚洲av免费高清在线观看| 99久久久亚洲精品蜜臀av| 少妇人妻精品综合一区二区 | av欧美777| 99久久成人亚洲精品观看| 中文字幕人妻丝袜一区二区| 看黄色毛片网站| 深爱激情五月婷婷| 国产精品98久久久久久宅男小说| 一本一本综合久久| av天堂在线播放| 蜜桃亚洲精品一区二区三区| 国产蜜桃级精品一区二区三区| 两个人看的免费小视频| 啦啦啦免费观看视频1| 久久久久精品国产欧美久久久| 88av欧美| 91在线观看av| 老鸭窝网址在线观看| 精品一区二区三区视频在线观看免费| 国产成人aa在线观看| 日本与韩国留学比较| 99热这里只有精品一区| 美女高潮喷水抽搐中文字幕| 看黄色毛片网站| а√天堂www在线а√下载| 国产精品99久久99久久久不卡| 青草久久国产| 婷婷精品国产亚洲av在线| 亚洲av不卡在线观看| 色吧在线观看| 午夜免费男女啪啪视频观看 | 日本成人三级电影网站| 麻豆国产av国片精品| av中文乱码字幕在线| 一卡2卡三卡四卡精品乱码亚洲| 国产精品免费一区二区三区在线| 丁香六月欧美| 岛国在线免费视频观看| 午夜福利在线观看免费完整高清在 | 男女床上黄色一级片免费看| 少妇的逼水好多| av视频在线观看入口| 三级男女做爰猛烈吃奶摸视频| 麻豆成人午夜福利视频| 亚洲国产精品999在线| 久久伊人香网站| 哪里可以看免费的av片| 两性午夜刺激爽爽歪歪视频在线观看| 国产成人影院久久av| 成人国产一区最新在线观看| 老司机午夜福利在线观看视频| 国产精品久久久人人做人人爽| 欧美最黄视频在线播放免费| 国产伦人伦偷精品视频| 亚洲 欧美 日韩 在线 免费| 在线免费观看不下载黄p国产 | 伊人久久大香线蕉亚洲五| 久久久国产成人精品二区| 婷婷六月久久综合丁香| 日日摸夜夜添夜夜添小说| 51午夜福利影视在线观看| 日韩中文字幕欧美一区二区| 日本撒尿小便嘘嘘汇集6| 亚洲美女视频黄频| 国产欧美日韩精品一区二区| 18禁美女被吸乳视频| 99视频精品全部免费 在线| 午夜激情欧美在线| 亚洲美女视频黄频| 看片在线看免费视频| 欧美激情在线99| 亚洲中文字幕一区二区三区有码在线看| 无人区码免费观看不卡| 国产高清激情床上av| 国产激情欧美一区二区| 欧美zozozo另类| 我的老师免费观看完整版| 亚洲一区高清亚洲精品| 国产私拍福利视频在线观看| 看黄色毛片网站| 嫩草影院入口| 日韩精品青青久久久久久| 精品久久久久久成人av| 国产一区二区激情短视频| 国产毛片a区久久久久| 亚洲av免费高清在线观看| 亚洲自拍偷在线| 中文在线观看免费www的网站| 噜噜噜噜噜久久久久久91| 婷婷精品国产亚洲av| 久99久视频精品免费| 国产不卡一卡二| 窝窝影院91人妻| 岛国在线免费视频观看| 一区二区三区高清视频在线| 欧美成人免费av一区二区三区| 天堂动漫精品| 日韩国内少妇激情av| tocl精华| 3wmmmm亚洲av在线观看| 中文字幕久久专区| 久久久久久久精品吃奶| 国产乱人视频| 亚洲人成网站在线播| 国产成人福利小说| 岛国在线观看网站| 午夜老司机福利剧场| 亚洲国产高清在线一区二区三| 女警被强在线播放| www.色视频.com| 欧美日本视频| 国产亚洲av嫩草精品影院| 国产野战对白在线观看| 蜜桃久久精品国产亚洲av| 免费av毛片视频| 亚洲av不卡在线观看| 99久久成人亚洲精品观看| 国产精品久久久人人做人人爽| 国产精品永久免费网站| 一区福利在线观看| 亚洲人成网站在线播| 色噜噜av男人的天堂激情| 亚洲久久久久久中文字幕| 国产精品av视频在线免费观看| 色尼玛亚洲综合影院| 国产精品,欧美在线| 两个人看的免费小视频| 床上黄色一级片| 18禁黄网站禁片午夜丰满| 日韩中文字幕欧美一区二区| 成年人黄色毛片网站| 三级国产精品欧美在线观看| 国产成人aa在线观看| 精品久久久久久,| 欧洲精品卡2卡3卡4卡5卡区| 久久婷婷人人爽人人干人人爱| 国产精品久久久久久久久免 | 国内精品美女久久久久久| 真人一进一出gif抽搐免费| 亚洲成人久久性| 最近在线观看免费完整版| 伊人久久大香线蕉亚洲五| 少妇的丰满在线观看| 久久精品国产亚洲av香蕉五月| 国产色爽女视频免费观看| 国产一区二区在线av高清观看| 免费av观看视频| 搡老妇女老女人老熟妇| 亚洲av五月六月丁香网| 狠狠狠狠99中文字幕| 国产精品1区2区在线观看.| 国模一区二区三区四区视频| 精品国产亚洲在线| 一进一出抽搐动态| 国产午夜精品久久久久久一区二区三区 | 国产亚洲欧美在线一区二区| 欧美乱码精品一区二区三区| 亚洲欧美日韩卡通动漫| 熟女电影av网| 熟女人妻精品中文字幕| 欧美av亚洲av综合av国产av| 99久久成人亚洲精品观看| 有码 亚洲区| 免费看光身美女| 日本一二三区视频观看|